[go: up one dir, main page]

WO2002009668A3 - Pulmonary administration of flint - Google Patents

Pulmonary administration of flint Download PDF

Info

Publication number
WO2002009668A3
WO2002009668A3 PCT/US2001/021105 US0121105W WO0209668A3 WO 2002009668 A3 WO2002009668 A3 WO 2002009668A3 US 0121105 W US0121105 W US 0121105W WO 0209668 A3 WO0209668 A3 WO 0209668A3
Authority
WO
WIPO (PCT)
Prior art keywords
flint
pulmonary administration
inhalation
administering
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/021105
Other languages
French (fr)
Other versions
WO2002009668A2 (en
Inventor
Radmila Micanovic
Derrick Ryan Witcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to AU2001280460A priority Critical patent/AU2001280460A1/en
Publication of WO2002009668A2 publication Critical patent/WO2002009668A2/en
Publication of WO2002009668A3 publication Critical patent/WO2002009668A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The claimed invention relates to methods and compositions for administering FLINT by inhalation, and a methods for treating a disease by administering FLINT by inhalation.
PCT/US2001/021105 2000-08-02 2001-07-20 Pulmonary administration of flint Ceased WO2002009668A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280460A AU2001280460A1 (en) 2000-08-02 2001-07-20 Pulmonary administration of flint

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22247600P 2000-08-02 2000-08-02
US60/222,476 2000-08-02

Publications (2)

Publication Number Publication Date
WO2002009668A2 WO2002009668A2 (en) 2002-02-07
WO2002009668A3 true WO2002009668A3 (en) 2002-05-10

Family

ID=22832374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021105 Ceased WO2002009668A2 (en) 2000-08-02 2001-07-20 Pulmonary administration of flint

Country Status (2)

Country Link
AU (1) AU2001280460A1 (en)
WO (1) WO2002009668A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729062C (en) 1997-01-14 2004-03-25 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6alpha & 6beta
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037094A2 (en) * 1998-12-22 2000-06-29 Eli Lilly And Company Therapeutic applications of flint polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037094A2 (en) * 1998-12-22 2000-06-29 Eli Lilly And Company Therapeutic applications of flint polypeptides

Also Published As

Publication number Publication date
AU2001280460A1 (en) 2002-02-13
WO2002009668A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
WO2002047668A3 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
WO2002083079A3 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
WO2001051071A3 (en) Transepithelial delivery of glp-1 derivatives
WO2002080965A3 (en) Vaccine composition
IL155283A0 (en) Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
YU36302A (en) Novel tiotropium preparation -containing inhalation powder
PT1458360E (en) Pulmonary delivery of aminoglycosides
WO2002070438A3 (en) Compositions for delivering bisphosphonates
GB0012362D0 (en) Chemical compounds
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
WO2002102318A3 (en) Eglin c based drugs for treatment of disease
WO2001060343A3 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
WO2003018535A3 (en) Novel aminobenzoephenones
WO2002060533A3 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
WO2002009668A3 (en) Pulmonary administration of flint
WO2004047829A8 (en) New synergistic combination comprising roflumilast and formoterol
WO2001049651A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives
SE0000303D0 (en) Novel compounds
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
WO2006012536A3 (en) Methods and compositions for treating lactose intolerance
WO2002069944A3 (en) Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP